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Objectives. We sought to assess the angiographic outcome,
complication rates and clinical features of percutaneous translu-
minal coronary angioplasty (PTCA) after failed thrombolysis for
acute myocardial infarction.
Background. “Rescue angioplasty” refers to mechanical re-
opening of an occluded infarct-related artery (IRA) after failed
intravenous thrombolysis. Although the procedure is commonly
performed, data describing its technical and clinical outcome are
sparse. Early reports suggested that rescue PTCA is less often
successful and produces more complications than primary PTCA.
Other reports have described beneficial effects of successful rescue
PTCA but adverse outcomes when PTCA is unsuccessful.
Methods. Using data from the Global Utilization of Streptoki-
nase and Tissue Plasminogen Activator for Occluded Coronary
Arteries (GUSTO-1) angiographic substudy, we compared clinical
and angiographic outcomes of 198 patients selected for a rescue
PTCA attempt with those of 266 patients with failed thrombolysis
but managed conservatively and, for reference, with those of 1,058
patients with successful thrombolysis.
Results. Patients offered rescue PTCA had more impaired left
ventricular function than those in whom closed vessels were
managed conservatively. Rescue successfully opened 88.4% of
closed arteries, with 68% attaining Thrombolysis in Myocardial
Infarction (TIMI) grade 3 flow. The interventions did not increase
catheterization laboratory or postprocedural complication rates.
Multivariate analysis identified severe heart failure to be a
determinant of a failed rescue attempt. Successful rescue PTCA
resulted in superior left ventricular function and 30-day mortality
outcomes, comparable to outcomes in patients with closed IRAs
managed conservatively, but less favorable than in patients in
whom thrombolytic therapy was initially successful. The mortality
rate after a failed rescue attempt was 30.4%; however, five of the
seven patients who died after failed rescue PTCA were in cardio-
genic shock before the procedure.
Conclusions. Rescue PTCA tends to be selected for patients
with clinical predictors of a poor outcome. It is effective in
restoring patency. Patients who die after a failed rescue attempt
are often already in extremis before the angioplasty attempt.
(J Am Coll Cardiol 1998;31:1511–7)
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“Rescue angioplasty” refers to mechanical reopening of an
occluded infarct-related artery (IRA) after failed intravenous
thrombolysis. Although this procedure is common, data de-
scribing its technical and clinical outcomes are sparse. Early
reports have suggested that percutaneous transluminal coro-
nary angioplasty (PTCA) of the IRA is less often technically
successful and more often associated with complications when
performed early after intravenous thrombolytic therapy than
when performed de novo (i.e., primary PTCA) (1–3). Support
for the efficacy of rescue PTCA has been provided by Ellis et
al. (4) in a small and highly selected group. This report
describes the angiographic outcome, complication rates and
clinical features regarding PTCA after failed thrombolysis in
198 patients treated in the Global Utilization of Streptokinase
and Tissue Plasminogen Activator for Occluded Coronary
Arteries (GUSTO-1) angiographic trial (5). Uniquely, the
present study is prospective, compares results according to
randomized thrombolytic assignment and includes protocol-
driven follow-up angiography.
Methods
Patient group. The performance of and outcome from
rescue PTCA was a prespecified end point of the GUSTO-1
angiographic study of four thrombolytic regimens in patients
with acute myocardial infarction (MI). The study was con-
ducted in 76 centers in North America, Europe and Australia
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participating in the GUSTO-1 mortality trial. The entry crite-
ria have been previously described (5,6); briefly, the study
enrolled patients with ST segment elevation and chest pain
duration ,6 h. The study was approved by each site’s Institu-
tional Review Board, and all patients gave written informed
consent.
Treatment and angiographic randomization. The thera-
peutic and angiographic randomization strategies have been
previously described (5,6). Patients received one of four treat-
ment regimens: streptokinase (SK) (Kabbekinase, Kabi Vit-
rum, Sweden) with intravenous heparin (sodium heparin,
Sanofi, Paris), adjusted to maintain an activated partial throm-
boplastin time between 60 and 80 s; SK with subcutaneous
heparin, 12,500 U twice daily, beginning 4 h after thrombolytic
initiation; tissue-type plasminogen activator (t-PA) (alteplase,
Genentech) given in an accelerated dosing regimen with
intravenous heparin; and a combination arm consisting of
reduced-dose SK and t-PA with intravenous heparin. At the
time of thrombolytic treatment randomization, patients were
also randomized to one of four times for initial angiography
after thrombolytic initiation. The times were 90 min, 180 min,
24 h and 5 to 7 days. All patients enrolled in the 90-min group
were also scheduled for follow-up angiography 5 to 7 days
later.
Coronary angiography and core angiographic laboratory
procedures. This report concerns patients who were enrolled
in the angiographic substudy and who were assigned to angiog-
raphy 90 or 180 min after thrombolytic therapy. Rescue PTCA
was defined as attempted guide wire crossing and balloon
dilation of a closed IRA (Thrombolysis In Myocardial Infarc-
tion trial [TIMI] flow grade 0 or 1) undertaken within 6 h from
the start of thrombolytic therapy. By protocol, rescue PTCA
was permitted but not required when an occluded IRA was
encountered. Therefore, the patients in this report underwent
mechanical reperfusion at the operator’s discretion and not by
random assignment. Rescue PTCA success was defined as
attainment of TIMI flow grade 2 or 3 in the infarct-related
vessel.
Details of core laboratory procedures have been previously
described (5). Briefly, angiographic films were interpreted by
an experienced angiographer (C.F.L., J.S.R. or A.M.R.) who
had no knowledge of the treatment, angiographic randomiza-
tion and clinical outcome. The first injection of the IRA was
used to determine the TIMI flow grade (7). The final angio-
graphic sequence filmed after rescue PTCA was used to
determine the TIMI flow grade resulting from the interven-
tion.
Two orthogonal views of the IRA were digitally acquired
and quantitatively analyzed. Quantitative coronary analysis
was performed, after manual centerline placement, using a
first- and second-derivative edge-detection algorithm (ARTREK,
University of Michigan). Lesion variables obtained included
percent diameter stenosis and minimal lumen diameter. For
determination of percent diameter stenosis, a “normal” refer-
ence segment was identified proximal to the stenosis. When
two views were technically adequate, the more severe mea-
sured stenosis of the two views was used for this analysis.
End-systolic and end-diastolic ventriculographic silhou-
ettes, defined by the core laboratory angiographer, were
digitized and stored. The analysis was limited to images
derived from a 30° right anterior oblique ventriculogram.
Ejection fraction was calculated by software (VENTREK,
University of Michigan) using the area–length method (8).
Regional wall motion, defined as the mean excursion of the
most abnormal 50% of chords, was calculated using the
method described by Bolson et al. (9). Additional charac-
terization of wall motion included determining the number
of consecutive chords in the infarct zone .2 SD below the
norm.
Because clinical outcomes of the two SK groups in the
mortality trial were similar (6) and because patients assigned to
SK with subcutaneous heparin received intravenous heparin in
the angiographic substudy to support the early diagnostic and
particularly interventional procedures, both SK groups were
considered comparable and are combined in this analysis.
Statistical analysis. Results are expressed as the mean
value 6 SD unless otherwise noted. The chi-square test was
used to compare categoric variables. Pairwise comparisons of
more than two proportions were analyzed using the Bonferroni
adjustment. Continuous end points of only two groups were
compared by using the unpaired Student t test; all p values are
two-tailed. Continuous end points of more than two groups
were compared by using analysis of variance and the Tukey
posterior test. A p value #0.05 was considered significant.
Statistical analysis was performed utilizing SAS software (SAS
Institute, Inc.).
Results
Patient characteristics. Of the 1,613 patients randomized
to undergo protocol angiography at 90 or 180 min after
initiation of thrombolytic therapy, 1,522 patients (94%) under-
went the procedure within 6 h. Of this group, 464 patients
(30%) had closed infarct-related vessels (TIMI flow grade 0 or
1); of these, 198 (43%) had attempted rescue PTCA.
Table 1 displays the incidence of failed thrombolysis and
rescue PTCA for the treatment assignments. Rescue PTCA
was attempted when a closed IRA was encountered in a similar
proportion across all treatment assignments.
Abbreviations and Acronyms
GUSTO 5 Global Utilization of Streptokinase and Tissue
Plasminogen Activator for Occluded Coronary
Arteries
IRA 5 infarct-related artery
MI 5 myocardial infarction
PTCA 5 percutaneous transluminal coronary angioplasty
SK 5 streptokinase
TIMI 5 Thrombolysis in Myocardial Infarction trial
t-PA 5 tissue-type plasminogen activator
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With the exceptions of the incidence of diabetes, which was
more common in patients in whom rescue PTCA was at-
tempted, and of a strong trend for angioplasty to be offered to
patients with hypotension, the baseline demographic charac-
teristics were similar between patients selected for a rescue
PTCA attempt and those with closed vessels managed by
noninterventional methods (Table 2).
Table 3 lists angiographic and ventriculographic character-
istics of the two groups of patients with failed thrombolysis
(those in whom rescue PTCA was attempted and those man-
aged conservatively). By all measures of global or regional
systolic function, patients with more impaired left ventricular
function were those more frequently offered rescue PTCA.
Table 4 details the technical results of rescue according to
thrombolytic treatment assignment. Rescue successfully re-
opened 175 (88.4%) of 198 closed arteries (conversion to TIMI
flow grades 2 or 3), with 41 (20.7%) of 198 becoming TIMI
flow grade 2 and 134 (67.7%) of 198 becoming TIMI flow
grade 3. We observed no thrombolytic drug-specific differences
in patency outcomes after rescue PTCA. The quantitative
angiographic indices of minimal lumen diameter and percent
diameter stenosis after rescue PTCA were also similar across
treatment groups. Patients who had successful rescue PTCA
left the catheterization laboratory with a larger lumen in the
infarct-related vessel compared with those who had thrombo-
lytic success (minimal lumen diameter 1.40 6 0.44 vs. 0.82 6
0.47, p 5 0.0001; percent diameter stenosis 46.2 6 13.7 vs.
66.3 6 14.1, p 5 0.0001).
For patients with successful rescue PTCA assigned to initial
angiography at 90 min, protocol-directed follow-up angiogra-
phy was performed in 116 (66.3%) of 175 at a mean of 5.9 6
2.4 days after enrollment. Of this group, 13 (11.2%) of 116
were found to have reoccluded infarct-related vessels. Three of
the 29 vessels (10.3%) that were TIMI flow grade 2 after rescue
PTCA became reoccluded, compared with 10 (11.5%) of 87
vessels that were TIMI flow grade 3 (p 5 0.87). For compar-
ison, patients who had successful thrombolysis and who under-
went protocol-driven follow-up angiography had a reocclusion
rate of 5.6%.
Table 5 compares the baseline and angiographic character-
istics of patients undergoing attempted rescue PTCA, stratified
by whether the procedure was ultimately successful or unsuc-
cessful. Multivariable logistic regression analysis found only
the presence of severe heart failure (Killip class .2) to be a
determinant of a failed rescue PTCA procedure (odds ratio
0.146, 95% confidence interval 0.035 to 0.631).
The rates of procedure-related complications for rescued
and nonrescued patients with thrombolytic failure are shown in
Table 6. For reference, this table also shows complication rates
for patients with successful thrombolysis undergoing only
diagnostic catheterization at 90 or 180 min after thrombolytic
initiation. Overall, the incidence of complications related to
rescue PTCA was low and similar to that of patients not
undergoing rescue PTCA.
Table 1. Incidence of Failed Thrombolysis and Rescue Angioplasty
SK
(n 5 753)
t-PA
(n 5 381)
SK and t-PA
(n 5 388)
Failed thrombolysis 292 (38.8%) 77 (20.2%)* 95 (24.5%)
Rescue PTCA attempted 123 (42.1%) 32 (41.6%) 43 (45.3%)
*p # 0.025 indicates statistical significance for each of the two posterior
pairwise comparisons by the Bonferroni adjustment: p 5 0.001 for t-PA versus
SK; p 5 NS for t-PA versus SK and t-PA. Data are presented as number (%) of
patients. PTCA 5 percutaneous transluminal coronary angioplasty; SK 5
streptokinase; t-PA 5 tissue-type plasminogen activator.
Table 2. Baseline Clinical Characteristics of Patients With Failed
Thrombolysis With and Without Rescue Angioplasty
Rescue PTCA
Attempted
(n 5 198)
No Rescue PTCA
Attempted
(n 5 266) p Value
Age (years) 59.6 (51.2, 68.7) 60.4 (52.5, 69.0) 0.45
Male (%) 76.3 81.1 0.20
Anterior MI (%) 38.9 35.5 0.45
Time to treatment (h) 3.3 (2.1, 4.3) 3.3 (2.0, 4.1) 0.99
Entry Killip class
.2 (%)
4.6 2.3 0.17
Entry systolic BP
,100 mm Hg (%)
11.1 6.4 0.07
Previous MI (%) 9.6 13.6 0.20
Diabetes (%) 17.2 9.4 0.01
Results in parentheses are 25th and 75th percentiles. BP 5 blood pressure;
MI 5 myocardial infarction; PTCA 5 percutaneous transluminal coronary
angioplasty.
Table 3. Angiographic and Ventriculographic Characteristics of Patients With Failed Thrombolysis
Rescue PTCA
Attempted
(n 5 198)
No Rescue PTCA
Attempted
(n 5 266) p Value
Multivessel CAD (%) 40.9 45.5 0.33
Initial ejection fraction (%) 53.8 (45.1, 63.4) 56.6 (48.7, 67.3) 0.05
Initial IZWM (SD/chord) 23.03 (23.79, 22.37) 22.64 (23.46, 22.03) 0.003
Initial abnormal chords (no.) 28.6 (16, 40) 24.1 (12, 32) 0.008
Results in parentheses are 25th and 75th percentiles. CAD 5 coronary artery disease; IZWM 5 infarct zone wall
motion; PTCA 5 percutaneous transluminal coronary angioplasty.
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Table 7 shows measures of left ventricular function ob-
tained in patients undergoing scheduled follow-up ventriculog-
raphy at 5 to 7 days. Successful rescue PTCA resulted in
superior convalescent left ventricular function outcomes, com-
parable to patients with closed IRAs managed conservatively,
but less favorable than in patients in whom thrombolytic
therapy was initially successful.
Survival data at 30 days for the rescue group and for the
entire 90-min and 180-min angiographic cohort are displayed
in Figure 1. Patients with successful thrombolysis had the
lowest 30-day mortality rate, followed by those with successful
rescue PTCA and those in whom no rescue was attempted.
Patients with failed rescue attempts had the highest death rate.
Of significance is that five of the seven patients who died after
rescue failure were noted to have been in cardiogenic shock at
the start of the catheterization laboratory procedure (Table 8).
The overall impact of shock on mortality in this series is
displayed in Table 9.
Intraaortic balloon pumps were used frequently in patients
in cardiogenic shock (11 of 20) undergoing rescue PTCA. Nine
of these patients died nonetheless; of the nine other patients in
shock not treated with a balloon pump, eight died.
In no rescue failure fatality was there evidence to implicate
that the procedure was a technical contributing factor in the
death.
Discussion
This study describes the largest prospective and prespeci-
fied series to date of rescue PTCA procedures. It uniquely
incorporates systematic, protocol-driven, early and convales-
cent angiographic and clinical outcome measures. In addition,
it provides results stratified by randomly assigned thrombolytic
treatment regimens.
Success of rescue PTCA. The findings provide strong evi-
dence that rescue PTCA in patients who have failed to
reperfuse after intravenous thrombolytic therapy for acute MI
is very effective in restoring patency and that success is not
influenced by the specific thrombolytic agent used. In an
earlier study of 78 patients undergoing rescue PTCA, Ellis et
al. (4) reported an angioplasty success rate of 92%. The Cohort
of Rescue Angioplasty in Myocardial Infarction (CORAMI)
study group reported a success rate of 90% (10). Recently, the
Table 4. Technical Results of Attempted Rescue Angioplasty
SK
(n 5 123)
t-PA
(n 5 32)
SK and t-PA
(n 5 43)
Conversion to TIMI 2 25 (20.3%) 8 (25.0%) 8 (18.6%)
Conversion to TIMI 3 83 (67.5%) 21 (65.6%) 30 (69.8%)
Conversion to TIMI 2 or 3 108 (87.8%) 29 (90.6%) 38 (88.4%)
Post-PTCA DS (%) 45.3 6 13.8 46.3 6 15.4 43.0 6 13.4
Post-PTCA MLD (mm) 1.42 6 0.46 1.46 6 0.44 1.53 6 0.55
Data are presented as number (%) of patients or mean value 6 SD. All p
values are not significant. DS 5 diameter stenosis; MLD 5 minimal lumen
diameter; TIMI 5 Thrombolysis in Myocardial Infarction flow grade; other
abbreviations as in Table 1.
Table 5. Characteristics of Patients With Attempted Rescue Angioplasty
Rescue Successful
(n 5 175)
Rescue Unsuccessful
(n 5 23) p Value
Age (years) 59.4 (51.2, 68.5) 60.7 (51.7, 70.5) 0.62
Male (%) 76.0 78.3 0.81
Anterior MI (%) 38.9 39.1 0.98
Time to treatment (h) 3.3 (2.1, 4.4) 2.9 (2.1, 3.5) 0.14
Entry Killip class .2 (%) 2.9 17.4 0.002
Entry systolic BP ,100 mm Hg (%) 11.4 8.7 0.70
Previous MI (%) 8.6 17.4 0.18
Diabetes (%) 16.0 26.1 0.23
Multivessel disease (%) 38.9 56.5 0.11
Ejection fraction (%) 54.0 (45.3, 63.4) 52.0 (37.8, 65.4) 0.70
IZWM (SD/chord) 23.05 (23.79, 22.35) 22.89 (23.61, 22.87) 0.71
Abnormal chords (no.) 28.2 (16, 40) 31.9 (20, 40) 0.40
Data are presented as mean value (25th and 75th percentiles). Abbreviations as in Tables 2 and 3.
Table 6. Procedure-Related Complications
Thrombolytic Failure Thrombolytic Success
Rescue
Attempted
(n 5 198)
No Rescue
Attempted
(n 5 266)
Catheterization at 90
or 180 min
(n 5 1,058)
Major bleeding* 8.6 6.8 6.0
Surgical repair 2.0 1.5 1.8
Emergency CABG 1.0 0.4 0.6
Stroke 0.5 0 0
*Major bleeding includes intracerebral bleeding and bleeding requiring
transfusion $2 U blood. Data are presented as percentage of patients. No
intergroup differences were statistically significant. CABG 5 coronary artery
bypass graft surgery.
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TIMI group reported a success of 90% from 58 rescue
attempts in the TIMI-4 trial (11). In the present study, PTCA
restored TIMI flow grade 2 or 3 in 88% of patients. Our data,
as well as those of the earlier, small studies, contradict the
notion that rescue PTCA will not be as technically successful as
in those referred for PTCA without antecedent lytic drugs
(“primary PTCA”). A review of the published data reveals an
aggregate success rate of 94% from five small primary PTCA
studies (12–16). In the large Global Use of Strategies To Open
occluded arteries in acute coronary syndromes (GUSTO IIb)
angiographic substudy (17), the success rate for primary PTCA
was 93% with a TIMI flow grade 3 outcome in 73%. In our
rescue PTCA group, the aggregate rate of TIMI flow grade 3
was 68%. It is important to emphasize that the previous studies
used differing definitions of success and only three of these
studies (10,12,17) used the attainment of TIMI flow grade 2 or
3 in the definition of primary PTCA success.
Complications of rescue PTCA. Our findings also help
dispel the concept that noncoronary complication rates after
rescue PTCA are high. The consensus that PTCA in a throm-
bolytic milieu is a dangerous combination is derived principally
from two trials: TIMI IIA (1) and Streptokinase Angioplasty
Myocardial Infarction trial (SAMI) (2), both of which reported
significantly higher rates of bleeding and emergency coronary
artery bypass graft surgery in patients undergoing PTCA in the
perithrombolytic period. In SAMI, 122 patients were random-
ized to direct PTCA or 1.5 million U of SK followed by
angioplasty of the infarct-related vessel. The trial found no
significant differences in PTCA success (98% for SK plus
angioplasty vs. 93% for angioplasty alone). The group given
thrombolytic therapy before PTCA did, however, demonstrate
a substantially increased incidence of emergency bypass sur-
gery (10% vs. 2%, p 5 0.03) and bleeding complications
requiring transfusion (39% vs. 8%). In contrast, in the present
study, the rate of emergency bypass surgery in patients under-
going rescue PTCA was only 1%, and the incidence of major
bleeding was 8.6%, equivalent to the rate in patients undergo-
ing protocol-driven diagnostic angiography alone.
We found that patients with thrombolytic success fared
better in terms of survival and convalescent ventricular func-
tion than those whose infarct-related vessel patency was
achieved only after rescue PTCA. This observation is consis-
tent with the advantage in time to patency in those patients
with infarct-related vessels already patent before arrival at the
angiographic laboratory compared with those who required a
catheterization laboratory rescue to establish IRA reperfusion.
Our data suggest that PTCA was usually selected for patients
with clinical predictors of a poor outcome (significantly worse
global and regional ventricular function). Successful rescue
PTCA appears to yield improved convalescent left ventricular
function, which becomes equivalent to that in patients not
offered rescue PTCA (who had significantly better left ventric-
ular indexes at the time of the early angiography).
Outcome after failed rescue PTCA. An intriguing finding in
this and previous reports is the very poor outcome in the
rescue-attempted-but-failed cohort. In our group of 23 such
patients, 7 (30.4%) died. A report from the Thrombolysis and
Figure 1. Thirty-day mortality rates for the rescue group and for the
entire 90-min and 180-min angiographic cohort. A p value #0.017
indicates statistical significance for each of the three posterior pairwise
comparisons by the Bonferroni adjustment: p 5 0.002 for rescue
success versus rescue failure; p 5 0.001 for rescue failure versus
thrombolytic failure managed conservatively; p 5 0.074 for rescue
success versus thrombolytic success.
Table 7. Left Ventricular Function at 5 to 7 Days
Rescue PTCA
Success
(n 5 98)
Rescue PTCA
Failure
(n 5 7)
Lytic Failure/
No PTCA
(n 5 150)
Lytic Success
(n 5 539)
Ejection fraction (%) 55.7 6 13.4 54.6 6 9.3 56.9 6 13.3 59.3 6 14.3
IZWM (SD/chord) 22.41 6 1.22 23.06 6 0.68 22.50 6 1.26 21.98 6 1.59
Abnormal chords (no.) 21.9 6 17.7 24.9 6 9.6 22.0 6 17.7 17.4 6 17.1
Data are presented as mean value 6 SD. Analysis of variance determined that at least one group mean was
significantly different from another group mean at the 0.05 level for IZWM and abnormal chords. Because of the unequal
group sizes and variances, the Tukey posterior test was performed to discern group differences. For abnormal chords, the
mean value of the lytic success group was statistically better than that of the rescue PTCA success group and the lytic
failure/no PTCA group. For IZWM, the mean value of the lytic success group was statistically better than that of the lytic
failure/no PTCA group. Abbreviations as in Table 3.
1515JACC Vol. 31, No. 7 ROSS ET AL.
June 1998:1511–7 RESCUE ANGIOPLASTY AFTER FAILED THROMBOLYSIS
Angioplasty in Myocardial Infarction (TAMI) trials (18) found
a similarly high mortality rate of 39.1% for patients with failed
rescue PTCA. Gorfinkel et al. (19) recently reported, in a
series of 125 patients, a mortality rate of 37.5% for those with
failed rescue PTCA. Although it has been postulated that
various components of the angioplasty procedure itself (nega-
tive inotropic effect of contrast, blood loss, intraluminal
trauma) may contribute to the observed high mortality in this
group of patients (18), our series indicates that the patients
who die are already in extremis before the angioplasty attempt.
In the present study, cardiogenic shock was already established
before arrival in the catheterization laboratory in five of the
seven patients who died after a failed rescue PTCA procedure.
Intraaortic balloon pumping, often employed in such patients
(20), did not provide evidence of benefit in this cohort.
Study limitations. These observations, although providing
a powerful data base on the technical aspects of rescue PTCA,
are only inferentially informative regarding the clinical utility
of the procedure, because discovery of failed thrombolysis in
this series was followed by an operator-determined clinical
decision (not a randomization) to leave the infarct-related
vessel closed or to attempt mechanical reopening. Baseline
imbalances, particularly in ventricular function, prohibit reach-
ing firm conclusions from the comparison of rescued versus
nonrescued patient groups, but suggest that PTCA is selected
for patients with clinical predictors of a poor outcome and is
usually successful in restoring coronary blood flow.
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